Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19–Convalescent Individuals

We have investigated the evolution of the neutralizing response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants at 8 months after Pfizer-BNT162b2 vaccination in coronavirus disease 2019 (COVID-19)–naive (n = 21) and COVID-19–convalescent (n = 21) individuals. Neutralizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Luczkowiak, Joanna, Labiod, Nuria, Rivas, Gonzalo, Rolo, Marta, Lasala, Fátima, Lora-Tamayo, Jaime, Mancheno-Losa, Mikel, Rial-Crestelo, David, Pérez-Rivilla, Alfredo, Folgueira, María Dolores, Delgado, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755312/
https://www.ncbi.nlm.nih.gov/pubmed/34963008
http://dx.doi.org/10.1093/infdis/jiab634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755312/
https://www.ncbi.nlm.nih.gov/pubmed/34963008
http://dx.doi.org/10.1093/infdis/jiab634

Ejemplares similares